Home/Bioventix/Peter Harrison
PH

Peter Harrison

Chief Executive Officer

Bioventix

Bioventix Pipeline

DrugIndicationPhase
Cardiac Troponin SMAsAcute Coronary SyndromeCommercial
Alzheimer's Tau Biomarker SMAs (p-tau, BD-tau)Alzheimer's DiseaseResearch/Commercial
Secretoneurin SMAsCardiovascular Risk StratificationCommercial
HOP-G (1-Hydroxypyrene Glucuronide) ELISA KitPolycyclic Aromatic Hydrocarbon (PAH) Exposure MonitoringCommercial
Drugs of Abuse SMAsToxicology / Forensic TestingCommercial